Big Gain For Atara Biotherapeutics, Inc.
Thu, Feb 01, 2024 at 07:24 PM
Atara Biotherapeutics, Inc. (ATRA:NASDAQ) soared at $0.83, a gain of 33.1%. On Thu, Feb 01, 2024, ATRA:NASDAQ touched a New 2-Week High of $0.83. The stock got featured on our News Catalysts scanner on Thu, Feb 01, 2024 at 03:32 AM in the 'BIOTECH' category. From Thu, Jan 18, 2024, the stock recorded 40.00% Up Days and 36.36% Green Days
About Atara Biotherapeutics, Inc. (ATRA:NASDAQ)
Atara Biotherapeutics Inc is engaged in the development of pharmaceutical products. Its focus lies on developing therapies addressing serious-life threatening diseases in the United States.
Top 10 Gainers:
- NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ), 67.28%
- Kiora Pharmaceuticals Inc. (KPRX:NASDAQ), 53.87%
- Trio Petroleum Corp. (TPET:NYSEMKT), 46.16%
- Ostin Technology Group Co. Ltd. (OST:NASDAQ), 45.85%
- WaveDancer Inc. (WAVD:NASDAQ), 44.74%
- Akso Health Group (AHG:NASDAQ), 35.67%
- Asset Entities Inc. (ASST:NASDAQ), 34.78%
- Atara Biotherapeutics, Inc. (ATRA:NASDAQ), 33.1%
- Roadzen Inc Ord Cl A (RDZN:NASDAQ), 29.41%
- Celularity Inc. (CELU:NASDAQ), 28.45%